RAGE signaling is known to drive the strength and maintenance of an inflammatory response and, as such, serve as a key player in bridging chronic inflammation and cancer (25), and using the murine CAC model, we found that in vivo treatment with SjE16.7 does indeed promote colorectal tumor progression. Here, MOK is linked to colorectal neoplasm.